Delcath Systems price to free cash flow DCTH
Market value divided by free cash flow over the last twelve months, since 2025.
- Today, Nov 2, 2026
- 28.3×
- Peer median
- 12.3×
Delcath Systems' price to free cash flow is 28.3× as of Nov 2, 2026.
The median for 10 medical instruments and supplies stocks of a similar size is 12.3×.
Price to free cash flow over time
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 28.3× | 14.7× | 34.0× |
| 2025 | 30.2× | 25.3× | 108× |
Against its peers
Companies in Medical - Instruments & Supplies nearest Delcath Systems' size, closest first, today.
| Company | Price to free cash flow |
|---|---|
| DCTHDelcath Systems | 28.3× |
| TCMDTactile Systems Technology | 19.3× |
| EMBCEmbecta | 2.1× |
| MOVMovado | 10.0× |
| INFUInfuSystem | 12.0× |
| IRMDIradimed | 38.9× |
| IARTIntegra Lifesciences | 12.3× |
| UTMDUtah Medical Products | 19.6× |
| BVSBioventus | 11.7× |
| STAAStaar Surgical | n/m |
| PDEXPro DEX | 17.3× |
| Peer median | 12.3× |
What the price to free cash flow tells you
Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.
Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.
More on Delcath Systems
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.